A carregar...
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
PURPOSE: More than a third of primary breast cancer patients are treated with cytotoxic chemotherapy, typically without guidance from predictive markers. Increased use of neoadjuvant chemotherapy provides opportunities for identification of molecules associated with treatment response, by comparing...
Na minha lista:
| Publicado no: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497675/ https://ncbi.nlm.nih.gov/pubmed/32734521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05836-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|